KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Change in Taxes (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Change in Taxes for 17 consecutive years, with -$324.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Taxes fell 367.77% to -$324.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.0 million, a 99.68% increase, with the full-year FY2025 number at -$4.0 million, up 99.68% from a year prior.
  • Change in Taxes was -$324.0 million for Q4 2025 at Bristol Myers Squibb, down from $887.0 million in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $1.0 billion in Q4 2023 to a low of -$2.1 billion in Q2 2023.
  • A 5-year average of -$217.6 million and a median of -$134.0 million in 2021 define the central range for Change in Taxes.
  • Peak YoY movement for Change in Taxes: plummeted 2222.73% in 2021, then surged 354.89% in 2025.
  • Bristol Myers Squibb's Change in Taxes stood at -$222.0 million in 2021, then plummeted by 401.35% to -$1.1 billion in 2022, then skyrocketed by 193.8% to $1.0 billion in 2023, then crashed by 88.41% to $121.0 million in 2024, then crashed by 367.77% to -$324.0 million in 2025.
  • Per Business Quant, the three most recent readings for BMY's Change in Taxes are -$324.0 million (Q4 2025), $887.0 million (Q3 2025), and -$621.0 million (Q2 2025).